Michael Hummel

Michael Hummel

Auto-generated profile, based on publicly available information

Michael Hummel

Charité – Universitätsmedizin Berlin, Institute of Pathology, Berlin, Germany

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1998 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
MSM Schirner
M Schirner
FHF Herzberg
F Herzberg
RSR Schmidt
R Schmidt
MSM Streit
M Streit
MSM Schöning
M Schöning
EKE D Kreuser
E D Kreuser

22 April 2020 in Genes, Chromosomes and Cancer
Verified
Journal Article
Open access
PDF file
MKMartina Kirchner
Martina Kirchner
JGJulia Glade
Julia Glade
ULUlrich Lehmann
Ulrich Lehmann
SMSabine Merkelbach-Bruse
Sabine Merkelbach-Bruse
MHMichael Hummel
Michael Hummel
NPNicole Pfarr
Nicole Pfarr
Gene fusions involving the three neurotrophic tyrosine receptor kinase genesNTRK1,NTRK2, orNTRK3were identified as oncogenic drivers in many cancer types. Two small molecule inhibitors have been tested in clinical trials recently and require the detection of aNTRKfusion gene prior to therapeutic application. Fluorescence in situ hybridization (FISH) and targeted next‐generation sequencing (tNGS) assays are commonly used for diagnostic profiling of gene fusions. In the presented study we applied an external quality assessment (EQA) scheme in order to investigate the suitability of FISH and RNA‐/DNA‐based tNGS for detection ofNTRKfusions in a multinational and multicentric ring trial. In total 27 participants registered for this study. Nine institutions took part in the FISH‐based and 18 in the NGS‐based round robin test, the latter additionally subdivided into low‐input and high‐input NGS methods (regarding nucleic acid input). Regardless of the testing method applied, all participants received tumor sections of 10 formalin‐fixed and paraffin‐embedded (FFPE) tissue blocks for in situ hybridization or RNA/DNA extraction, and the results were submitted via an online questionnaire. For FISH testing, eight of nine (88.8%) participants, and for NGS‐based testing 15 of 18 (83.3%) participants accomplished the round robin test successfully. The overall high success rate demonstrates that FISH‐ and tNGS‐basedNTRKtesting can be well established in a routine diagnostic setting. Complementing this dataset, we provide an updated in silico analysis on the coverage of more than 150NTRKfusion variants by several commercially available RNA‐based tNGS panels.

4 June 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMathias Streitz
Mathias Streitz
Michel NoutsiasMichel Noutsias
Michel Noutsias
RVRudolf Volkmer
Rudolf Volkmer
MRMaria Rohde
Maria Rohde
GBGordon Brestrich
Gordon Brestrich
FKFlorian Kern
Florian Kern
Parvovirus B19 (B19V) is the most commonly detected virus in endomyocardial biopsies (EMBs) from patients with inflammatory cardiomyopathy (DCMi). Despite the importance of T-cells in antiviral defense, little is known about the role of B19V specific T-cells in this entity. An exceptionally high B19V viral load in EMBs (115,091 viral copies/μg nucleic acids), peripheral blood mononuclear cells (PBMCs) and serum was measured in a DCMi patient at initial presentation, suggesting B19V viremia. The B19V viral load in EMBs had decreased substantially 6 and 12 months afterwards, and was not traceable in PBMCs and the serum at these times. Using pools of overlapping peptides spanning the whole B19V proteome, strong CD8+ T-cell responses were elicited to the 10-amico-acid peptides SALKLAIYKA (19.7% of all CD8+ cells) and QSALKLAIYK (10%) and additional weaker responses to GLCPHCINVG (0.71%) and LLHTDFEQVM (0.06%). Real-time RT-PCR of IFNγ secretion-assay-enriched T-cells responding to the peptides, SALKLAIYKA and GLCPHCINVG, revealed a disproportionately high T-cell receptor Vbeta (TRBV) 11 expression in this population. Furthermore, dominant expression of type-1 (IFNγ, IL2, IL27 and T-bet) and of cytotoxic T-cell markers (Perforin and Granzyme B) was found, whereas gene expression indicating type-2 (IL4, GATA3) and regulatory T-cells (FoxP3) was low. Our results indicate that B19V Ag-specific CD8+ T-cells with effector function are involved in B19V associated DCMi. In particular, a dominant role of TRBV11 and type-1/CTL effector cells in the T-cell mediated antiviral immune response is suggested. The persistence of B19V in the endomyocardium is a likely antigen source for the maintenance of CD8+ T-cell responses to the identified epitopes.

22 March 2016 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
VEVolker Endris
Volker Endris
Albrecht  StenzingerAlbrecht Stenzinger
Albrecht Stenzinger
NPNicole Pfarr
Nicole Pfarr
RPRoland Penzel
Roland Penzel
MMMarkus Möbs
Markus Möbs
PSPeter Schirmacher
Peter Schirmacher

11 July 2013 in Leukemia
Verified
Journal Article
Open access
LDL Dimitrova
L Dimitrova
VSV Seitz
V Seitz
JHJ Hecht
J Hecht
DLD Lenze
D Lenze
PHP Hansen
P Hansen
MHM Hummel
M Hummel
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.

7 August 2019 in Applied Clinical Informatics
Verified
Journal Article
Open access
PDF file
SMSebastian Mate
Sebastian Mate
MKMarvin Kampf
Marvin Kampf
WRWolfgang Rödle
Wolfgang Rödle
SKStefan Kraus
Stefan Kraus
RPRumyana Proynova
Rumyana Proynova
HPHans-Ulrich Prokosch
Hans-Ulrich Prokosch
Background High-quality clinical data and biological specimens are key for medical research and personalized medicine. The Biobanking and Biomolecular Resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC) aims to facilitate access to such biological resources. The accompanying ADOPT BBMRI-ERIC project kick-started BBMRI-ERIC by collecting colorectal cancer data from European biobanks. Objectives To transform these data into a common representation, a uniform approach for data integration and harmonization had to be developed. This article describes the design and the implementation of a toolset for this task. Methods Based on the semantics of a metadata repository, we developed a lexical bag-of-words matcher, capable of semiautomatically mapping local biobank terms to the central ADOPT BBMRI-ERIC terminology. Its algorithm supports fuzzy matching, utilization of synonyms, and sentiment tagging. To process the anonymized instance data based on these mappings, we also developed a data transformation application. Results The implementation was used to process the data from 10 European biobanks. The lexical matcher automatically and correctly mapped 78.48% of the 1,492 local biobank terms, and human experts were able to complete the remaining mappings. We used the expert-curated mappings to successfully process 147,608 data records from 3,415 patients. Conclusion A generic harmonization approach was created and successfully used for cross-institutional data harmonization across 10 European biobanks. The software tools were made available as open source.